People

Search Language

中文(台灣) / Traditional Chinese | Use language selector above (below, on mobile) to search additional languages
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(Venture Capital)

1072 items matching filters

Search Results

Practice:

  • Capital Markets
  • Technology Companies Group
  • Special Purpose Acquisition Companies (SPACs)

Bill Hughes Partner

San Francisco; Silicon Valley

Bill counsels public and late-stage private companies on general corporate and transactional matters, including advising on initial public offerings, follow-on equity offerings, direct listings, investment grade debt offerings and convertible debt offerings. He also regularly advises companies on disclosure and reporting obligations under U.S. federal securities laws, corporate governance issues and stock exchange listing obligations.

Additionally, Bill advises founders and companies in connection with public listings through SPAC merger. Among other engagements, Bill represented Getaround, Inc., a connected carsharing marketplace, Clover Health Investments, Corp., a next-generation Medicare Advantage insurer, and the founders of DraftKings Inc., a digital sports entertainment and gaming company, in the respective de-SPAC transactions of those entities.

Chambers USA has ranked Bill for his expertise in Capital Markets Debt & Equity and noted that "He's a great lawyer, really technically sound."

Practice:

  • Capital Markets
  • Technology Companies Group
  • Special Purpose Acquisition Companies (SPACs)

Bill Hughes Partner

San Francisco; Silicon Valley

Bill counsels public and late-stage private companies on general corporate and transactional matters, including advising on initial public offerings, follow-on equity offerings, direct listings, investment grade debt offerings and convertible debt offerings. He also regularly advises companies on disclosure and reporting obligations under U.S. federal securities laws, corporate governance issues and stock exchange listing obligations.

Additionally, Bill advises founders and companies in connection with public listings through SPAC merger. Among other engagements, Bill represented Getaround, Inc., a connected carsharing marketplace, Clover Health Investments, Corp., a next-generation Medicare Advantage insurer, and the founders of DraftKings Inc., a digital sports entertainment and gaming company, in the respective de-SPAC transactions of those entities.

Chambers USA has ranked Bill for his expertise in Capital Markets Debt & Equity and noted that "He's a great lawyer, really technically sound."

461799

Practice:

  • Antitrust & Competition

Neetu Ahlawat Associate

London

Neetu’s practice encompasses merger control and foreign direct investment, having represented clients in several big-ticket cases requiring complex remedies. She provides guidance on compliance and conducts a range of behavioural investigations for clients across multiple sectors.

Before joining Orrick, Neetu was part of the top-tier competition practice at one of India's largest law firms.

461799

Practice:

  • Antitrust & Competition

Neetu Ahlawat Associate

London

Neetu’s practice encompasses merger control and foreign direct investment, having represented clients in several big-ticket cases requiring complex remedies. She provides guidance on compliance and conducts a range of behavioural investigations for clients across multiple sectors.

Before joining Orrick, Neetu was part of the top-tier competition practice at one of India's largest law firms.

Practice:

  • Technology & Innovation Sector
  • Technology & Innovation
  • Technology Transactions
  • Intellectual Property
  • Strategic Advisory & Government Enforcement (SAGE)

Sarah Schaedler Partner

San Francisco

Sarah’s practice focuses on structuring and negotiating the intellectual property aspects of complex corporate transactions, including mergers and acquisitions, business divestitures and commercial transactions where software and technology are the principal assets. Sarah also advises on intellectual property and technology contracts related questions in the context of Artificial Intelligence (AI).

Sarah routinely advises on carve-outs and business separation transactions and helps clients with structuring and implementing their intellectual property and technology separation roadmap.

Sarah has counseled several companies in their preparation for a divestiture and understands the issues a buyer is focused on in the context of intellectual property matters. She regularly helps companies implement remediation steps around their intellectual property assets to help them to a successful closing.

She has significant experience advising private equity funds on investments involving companies that are driven by technology & innovation, as well as intellectual property reliant consumer product companies and companies that are stepping into digitalization.

Sarah is also a member of Orrick’s AI leadership group and involved in thought leadership projects related to AI matters on corporate transactions.

Educated and trained in Germany, France and the United States, Sarah’s international experience provides her with additional knowledge on cross-border transactions and international matters.

Practice:

  • Technology & Innovation Sector
  • Technology & Innovation
  • Technology Transactions
  • Intellectual Property
  • Strategic Advisory & Government Enforcement (SAGE)

Sarah Schaedler Partner

San Francisco

Sarah’s practice focuses on structuring and negotiating the intellectual property aspects of complex corporate transactions, including mergers and acquisitions, business divestitures and commercial transactions where software and technology are the principal assets. Sarah also advises on intellectual property and technology contracts related questions in the context of Artificial Intelligence (AI).

Sarah routinely advises on carve-outs and business separation transactions and helps clients with structuring and implementing their intellectual property and technology separation roadmap.

Sarah has counseled several companies in their preparation for a divestiture and understands the issues a buyer is focused on in the context of intellectual property matters. She regularly helps companies implement remediation steps around their intellectual property assets to help them to a successful closing.

She has significant experience advising private equity funds on investments involving companies that are driven by technology & innovation, as well as intellectual property reliant consumer product companies and companies that are stepping into digitalization.

Sarah is also a member of Orrick’s AI leadership group and involved in thought leadership projects related to AI matters on corporate transactions.

Educated and trained in Germany, France and the United States, Sarah’s international experience provides her with additional knowledge on cross-border transactions and international matters.

453686

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Amy M. Joseph Partner

Boston

Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.

Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.

In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.

A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.

Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”

Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.

453686

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Amy M. Joseph Partner

Boston

Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.

Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.

In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.

A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.

Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”

Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.

340902

Practice:

  • Finance Sector
  • Structured Finance
  • Banking & Finance
  • Capital Markets
  • Energy

Hervé Touraine Partner

Geneva; Paris

Hervé represents French and international financial institutions, corporates, sponsors, investors, insurance companies, asset managers and alternative capital providers on French and cross border transactions. He advises on banking, structured finance, securitization, and capital markets transactions.

Hervé has worked on numerous complex, strategic and/or innovative transactions (including many firsts in France and Europe) such as international securitization transactions, covered bonds, corporate structured bonds, project bonds, debt funds and the establishment of dedicated origination and refinancing platforms. He also acted on transactions for financing or refinancing purposes (including liquidity), and for off-balance sheet or regulatory capital purposes. As such, he has developed particular skills in handling multi-jurisdictions and multi-practices transactions.

He has developed a substantial experience in the energy and infrastructure sector in the context of financing and refinancing transactions, using classical bank structures as well as Euro PP, bond and project bond structures, specialized credit institutions and dedicated debt funds.

Hervé is described by his clients as a “key person” for structured finance deals, noting: “when we've got a problem, he's there. We know we can count on him”. Clients further comment: “He is dedicated and innovative, and an expert in is field. We see him as a business partner of ours, rather than a lawyer”.

Hervé is an active participant in drafting securitization and structured finance legislation and regulations in France. Hervé regularly publishes and speaks in relation to structure finance markets and related points of interest and deals.

Before joining Orrick in 2016, Hervé was a partner at Freshfields Bruckhaus Deringer LLP where he worked for 20 years, including 18 years as a partner.

340902

Practice:

  • Finance Sector
  • Structured Finance
  • Banking & Finance
  • Capital Markets
  • Energy

Hervé Touraine Partner

Geneva; Paris

Hervé represents French and international financial institutions, corporates, sponsors, investors, insurance companies, asset managers and alternative capital providers on French and cross border transactions. He advises on banking, structured finance, securitization, and capital markets transactions.

Hervé has worked on numerous complex, strategic and/or innovative transactions (including many firsts in France and Europe) such as international securitization transactions, covered bonds, corporate structured bonds, project bonds, debt funds and the establishment of dedicated origination and refinancing platforms. He also acted on transactions for financing or refinancing purposes (including liquidity), and for off-balance sheet or regulatory capital purposes. As such, he has developed particular skills in handling multi-jurisdictions and multi-practices transactions.

He has developed a substantial experience in the energy and infrastructure sector in the context of financing and refinancing transactions, using classical bank structures as well as Euro PP, bond and project bond structures, specialized credit institutions and dedicated debt funds.

Hervé is described by his clients as a “key person” for structured finance deals, noting: “when we've got a problem, he's there. We know we can count on him”. Clients further comment: “He is dedicated and innovative, and an expert in is field. We see him as a business partner of ours, rather than a lawyer”.

Hervé is an active participant in drafting securitization and structured finance legislation and regulations in France. Hervé regularly publishes and speaks in relation to structure finance markets and related points of interest and deals.

Before joining Orrick in 2016, Hervé was a partner at Freshfields Bruckhaus Deringer LLP where he worked for 20 years, including 18 years as a partner.

471413

Practice:

  • Technology Transactions
  • Intellectual Property
  • Trademark, Copyright & Media
  • Trade Secrets Litigation
  • Patents
  • Strategic Advisory & Government Enforcement (SAGE)

Simon Reulein Associate

Düsseldorf

He advises clients on intellectual property law, in particular in the context of IP license or assignment agreements, R&D collaborations, mergers and acquisitions or venture and other strategic transactions that involve the commercialization of IP.

Simon also advises clients on strategic IP protection and enforcement, in particular in the field of patent, trademark and copyright law.

Prior to joining Orrick, Simon was a trainee lawyer with three renown international law firms as well as with the German Federal Cartel Office.

471413

Practice:

  • Technology Transactions
  • Intellectual Property
  • Trademark, Copyright & Media
  • Trade Secrets Litigation
  • Patents
  • Strategic Advisory & Government Enforcement (SAGE)

Simon Reulein Associate

Düsseldorf

He advises clients on intellectual property law, in particular in the context of IP license or assignment agreements, R&D collaborations, mergers and acquisitions or venture and other strategic transactions that involve the commercialization of IP.

Simon also advises clients on strategic IP protection and enforcement, in particular in the field of patent, trademark and copyright law.

Prior to joining Orrick, Simon was a trainee lawyer with three renown international law firms as well as with the German Federal Cartel Office.